Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

One English pound placed on a graph to represent an economic down turn
Investing Articles

£7,000 to invest? I’d consider these stocks in the FTSE 100 right now

| Kevin Godbold

Like a resurgent Rolls-Royce, multiple FTSE 100 businesses can sometimes deliver decent returns for investors over a reasonable timescale.

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

They outperformed the S&P 500 over 5 years! Are these the best UK shares to buy now?

| Mark Hartley

Sure, the S&P 500 may deliver impressive returns, but I’m looking at three shares to buy here in the UK…

Read more »

Investing Articles

How I’d invest £20,000 in a Stocks and Shares ISA to target lifelong passive income

| Stephen Wright

What should investors look for when investing in a Stocks and Shares ISA? Stephen Wright thinks the key for passive…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down more than 10% in 2023, Fools are backing these 5 UK stocks to reverse that – and then some! – in 2024

| The Motley Fool Staff

Five Fools see buying opportunities among these beaten-down shares in the UK stock markets!

Read more »

The Mall in Westminster, leading to Buckingham Palace
Investing Articles

If I had to buy just one FTSE 100 stock in 2024, it would be this

| Ben McPoland

This Fool considered which FTSE 100 (INDEXFTSE:UKX) stock he’d buy next year if given only one choice. Here’s the champ…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Are these 2 FTSE 100 companies recession-resistant?

| Zaven Boyrazian, CFA

Zaven Boyrazian explores two FTSE 100 giants that could outperform the stock market in the event of a near-term recession…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

Here’s a FTSE 100 giant I’m eyeing up for December!

| Sumayya Mansoor

This Fool explains why this FTSE 100 pharma giant is on her radar. She plans to snap up shares for…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

Here’s 1 thriving FTSE 100 stock I’d snap up in November

| Zaven Boyrazian, CFA

Stock market volatility has created some exciting opportunities within FTSE 100 stocks. But is this business currently the best bargain?

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Value Shares

UK shares near 52-week lows: 2 I like and 1 I’d avoid

| Edward Sheldon, CFA

Edward Sheldon has been scanning the FTSE 350 index for shares trading near their 52-week lows and has identified a…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Does the AstraZeneca share price scream value?

| Dr. James Fox

Dr James Fox takes a closer look at the AstraZeneca share price following the company's Q3 results. Is this growth-focused…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

After a rocky October, are AstraZeneca shares now a buy?

| Gordon

AstraZeneca shares fell sharply in October following disappointing results in a clinical trial. Are they now primed for a bounce?

Read more »

Businesswoman calculating finances in an office
Investing Articles

What’s going on with the AstraZeneca share price?

| Mark Tovey

The AstraZeneca share price took a nasty nosedive last week. That came after bad news about a lung cancer drug…

Read more »